DX GLASS
DEAD

Serial Number

90145937

Owner

Recovery Exploration Technologies, Inc.

Attorney

Tina Chen

Filing Date

Aug 28, 2020

Add to watchlist:

No watchlists yet
View on USPTO

DX GLASS Trademark

Serial Number: 90145937

DX GLASS is a trademark filed by Recovery Exploration Technologies, Inc. on August 28, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Recovery Exploration Technologies, Inc. (8 trademarks)

255 Constitution Drive
Menlo Park, CA 94025

Entity Type: 03

EVIDIUM, INC. (11 trademarks)

44 TEHAMA STREET, SUITE 412
SAN FRANCISCO, CA 94105

Entity Type: 03

Trademark Details

Filing Date

August 28, 2020

Registration Date

Not Registered

Published for Opposition

February 13, 2024

Goods & Services

Digital and voice signal processors for use with mobile devices and tablets in the nature of a medical diagnostic apparatus that is capable of receiving voice input of symptoms for medical diagnostic purposes; voice transcription tool, being non-downloadable software, for mobile devices and tablets for receiving voice input of symptoms and transcribing the input for medical diagnostic purposes across all health fields

Medical services, namely, medical diagnostic services via a computer or communication network; providing medical diagnostic services relating to the treatment of persons via Internet-connected computer software and hardware; medical analysis and diagnostic services relating to the treatment of persons; providing medical information in the nature of a recommendation engine for medical information content on the Internet via a website

Medical device diagnostic hardware for use with mobile devices and tablets, namely, medical diagnostic apparatus that receives and uses input of symptoms for medical diagnostic purposes across various health fields, including cancer and diabetes, with embedded non-downloadable software for accessing interface for diagnosis support; Internet-connected medical diagnostic devices that receive input of symptoms and analyze the input for medical diagnostic purposes; medical diagnostic apparatus incorporating a hardware user-interface for receiving input of symptoms for medical diagnosis across various health fields, including cancer and diabetes, via a computer or communication network; medical diagnostic apparatus in the nature of mobile devices, tablets, and computer hardware with embedded software for providing a system of interaction for diagnostic inquiry, including receiving input of symptoms, for providing medical diagnosis hypotheses for all health fields and providing insights on and enabling users to explore in real-time diagnostic options across all health fields, real-time findings, and actions that might best support forming diagnosis hypotheses, namely, medical diagnostic mobile devices and tablets

Providing online, non-downloadable medical software for providing situational awareness of pertinent factors relating to diagnosis, in real-time validating or expanding differential diagnosis considerations, and providing suggestions to help optimize the downstream healthcare pathway for diagnosis and treatment; online non-downloadable software applications for helping determine medical diagnosis; online non-downloadable real-time recommendation engine software based on artificial intelligence and algorithms for medical diagnosis; Providing an online non-downloadable software database in the field of medical diagnosis; providing online non-downloadable computer software and hardware for medical diagnosis via a computer or communication network; providing online non-downloadable software featuring real-time recommendation engines based on artificial intelligence and algorithms for medical diagnosis; providing an Internet recommendation engine service based on artificial intelligence and algorithms featuring medical information in the field of augmented intelligence for diagnostic decision support across all health fields

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 14, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 14, 2025 ABN6
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 19, 2025 ASCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 16, 2024 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 9, 2024 EXRA
SOU EXTENSION 1 GRANTED
Oct 9, 2024 EX1G
SOU EXTENSION 1 FILED
Oct 7, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 7, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 9, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 13, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
May 8, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 8, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
May 8, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 8, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 5, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 5, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 9, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jan 9, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jan 9, 2023 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 3, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Nov 22, 2022 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 4, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 7, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 6, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 6, 2022 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Sep 8, 2022 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Sep 8, 2022 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Sep 8, 2022 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 26, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 25, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 10, 2022 GNFN
FINAL REFUSAL E-MAILED
Feb 10, 2022 GNFR
FINAL REFUSAL WRITTEN
Feb 10, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 13, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 12, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 12, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 13, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jul 13, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jul 13, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 9, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 9, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 31, 2020 GNRN
NON-FINAL ACTION E-MAILED
Dec 31, 2020 GNRT
NON-FINAL ACTION WRITTEN
Dec 31, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 29, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 2, 2020 NWOS
NEW APPLICATION ENTERED
Sep 1, 2020 NWAP